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The	emergence	of	system	sciences	such	as	Systems	Biology,	Systems	Medicine	and	Systems	
Pharmacology	[8,9]	over	the	past	two	decades	has	seen	a	rapid	growth	in	the	application	of	
mechanistic	mathematical	and	computational	models	in	the	biological,	biomedical	and	
pharmacological	sciences.	Such	models	have	been	formulated	to	elucidate	understanding	
and	provide	predictive	simulations	in	areas	as	diverse	as	tumour	growth	[1],	immunology	
[4],	pharmacology	[5],	bacterial	motility	[10]	and	the	physiology	of	the	heart	[6].	In	seeking	
to	provide	insight,	models	have	been	formulated	to	tackle	problems	at	the	subcellular,	
tissue,	organ	and	cohort	scales.	In	doing	so,	a	range	of	mathematical	modelling	approaches	
have	been	employed	including	differential	equations	and	multiscale	modelling	[3],	right	
through	to	more	computationally	based	ones	such	as	cellular	automata	and	hybrid	agent	
based	modelling	[7].	Each	approach	brings	with	it	its	own	benefits	and	issues,	but	ultimately	
is	focused	on	advancing	knowledge	of	the	underlying	system	to	which	it	has	been	applied.		
	
The	review	of	Belyaev	and	colleagues	[2]	in	this	issue	of	Physics	of	Life	Reviews	highlights	
both	modelling	to	date	and	the	need	for	further	modelling	in	the	field	of	hemostasis	and	
thrombosis	formation.	Whilst	critically	important	for	human	health	–	the	largest	causes	of	
death	are	a	result	of	disorders	in	the	area,	the	field	has	only	recently	begun	to	receive	more	
focused	attention	from	the	mathematical	and	computational	modelling	communities.	This	is	
important	because	as	a	whole	the	hemostasis	system	is	difficult,	if	not	impossible	to	isolate	
via	in	vitro	or	in	vivo	studies.	Whilst	“pieces”	of	it	can	be	isolated	in	vitro,	for	instance	
platelet	aggregration	at	the	cellular	scale,	an	informed	predictive	framework	is	required	
which	is	able	to	combine	individual	aspects	such	as	subcellular	biochemistry,	cell	signalling,	
cell	adhesion	and	fluid	dynamics	(in	often	complex	geometries),	to	understand	the	
regulation	of	in	vivo	regulated	processes	such	as	thrombosis	formation.	This	is	important	for	
a	number	of	reasons.		
	
Firstly,	such	a	framework	will	allow	aspects	of	the	system,	either	components	of	it	or	it	as	a	
whole,	to	be	elucidated.	Secondly,	such	a	tool	can	be	used	to	provide	future	clinical	
predictions	of	an	individual’s	hemostasis	wellbeing	based	on	their	current	status.	Indeed,	
we	can	envisage	a	world	in	which	blood	samples	from	patients	allows	their	risk	of	
hemostasis	related	diseases	to	be	stratified,	the	effect	of	their	therapeutic	treatments	to	be	
regularly	evaluated	and	the	need	for	future	interventions	to	be	identified,	all	via	patient	
sample	informed	predictive	modelling.	Finally,	at	the	level	of	basic	science	and	drug	
discovery,	such	a	framework	can	also	be	used	to	test	hypotheses	regarding	therapeutic	
strategies	and	identify	which	are	the	most	fruitful	routes	for	future	investigation.	
Mechanistic	mathematical	modelling	provides	a	plausible	platform	for	undertaking	this	task	
and	as	the	authors	point	out,	has	already	in	a	short	period	of	time,	been	effective	within	the	
field.		
	
This	review	makes	clear	the	wide	range	of	areas	within	the	hemostatis	system	that	have	
already	been	mathematically	modelled	and	the	modelling	approaches	which	have	been	
employed.	These	range	from	multiscale	discrete	models	of	platelet	adhesion	and	
aggregration	through	to	full	cell	models	of	erythrocyte	regulation	along	with	continuum	
models	describing	coagulation	under	flow.	As	Belyaev	et	al.	[2]	rightly	point	out,	each	
approach	is	able	to	provide	different	levels	of	insight	to	the	system.	Whilst	a	full	multiscale	
model	of	homeostasis	and	thrombosis	regulation	(from	the	subcellular	to	whole	individual	
scale)	would	be	ideal,	the	size	and	computational	cost	of	constructing	such	a	model	is	
currently	prohibitive.	Whilst	the	reviewers	highlight	the	need	for	informed	methods	for	
parallelising	such	largescale	models,	as	with	many	other	System	Science	application	areas,	
there	remains	an	open	requirement	for	mathematical	models	of	hemostasis	which	are	
simultaneously	able	to	capture	the	key	features	from	the	subcellular	to	whole	individual	
scale,	whilst	providing	useful	clinical	level	detail	in	real	time.		
	
Within	their	work	the	authors	provide	a	helpful	list	of	key	challenges,	both	biologically	and	
modelling,	within	the	field.	These	provide	useful	entry	points	to	those	new	to	the	field	from	
both	backgrounds	and	make	it	clear	that	tackling	such	challenges	will	not	only	further	our	
understanding	of	hemostasis	systems,	but	greatly	aid	in	ensuring	the	future	goal	of	an	
integrated	predictive	model	of	hemostasis	becomes	a	reality.	
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